CD14 and neoplasm: Consistent with our previous work in the murine system, we found that the monocytic CD14+ MDSC from these human tumor bearing humanized mice can suppress human T-cell activation ex vivo while the granulocytic CD15+MDSC failed to demonstrate this (Figure 6a) [22].